Angola vs Democratic Republic of Congo: Statin use vs. average non-HDL cholesterol levels
Statin use vs. average non-HDL cholesterol levels over time
- Angola
- Democratic Republic of Congo
How they compare
Angola currently reports 2.8 against 2.8 in Democratic Republic of Congo, a difference of 0.
The two have swapped places 6 times across 39 shared years of data; in 1980 it was Democratic Republic of Congo ahead.
Angola ranks 163rd and Democratic Republic of Congo ranks 163rd of 191 countries.
Across the 4 decades both report, Angola averaged higher in 3 and Democratic Republic of Congo in 1.
Head to head by decade
| Decade | Angola | Democratic Republic of Congo | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.57 | 2.58 | 0.01 | Democratic Republic of Congo |
| 1990s | 2.75 | 2.68 | 0.07 | Angola |
| 2000s | 2.83 | 2.75 | 0.08 | Angola |
| 2010s | 2.84 | 2.8 | 0.0444 | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Angola or Democratic Republic of Congo?
- Angola, at 2.8 against 2.8 in Democratic Republic of Congo as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Angola and Democratic Republic of Congo?
- 0, with Angola ahead.
- How many years of comparable data are there for Angola and Democratic Republic of Congo?
- 39 years are reported by both, from 1980 to 2018.
- How do Angola and Democratic Republic of Congo rank globally for statin use vs. average non-hdl cholesterol levels?
- Angola ranks 163rd and Democratic Republic of Congo ranks 163rd of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.